UChicago Medicine ASH 2024 Updates: Practice-Changing Abstracts 2025

UChicago Medicine ASH 2024 Updates: Practice-Changing Abstracts 2025

Hematology

Overview

UChicago Medicine ASH 2024 Updates: Practice-Changing Abstracts 2025An elite clinical review of the most impactful clinical data presented at the ASH Annual Meeting. Focuses on groundbreaking therapies including CAR T-cell, novel immunotherapies, and targeted agents.

ASH 2024 Data CAR T-cell Therapy Bispecific Antibodies Toxicity Management Hematologic Malignancies Course Date: February 28, 2025 • Delivery via Google Drive Program Overview Stay at the forefront of hematologic cancer management with the 10th Annual UChicago ASH Updates. This practice-focused course synthesizes cutting-edge data from the 2024 American Society of Hematology meeting into actionable clinical paradigms.

Academic oncologists and community providers evaluate critical considerations for sequencing novel agents, the role of stem cell transplantation in high-risk patients, and the integration of bispecific antibodies with varied therapeutic targets. Learning Objectives Identify emerging treatment strategies and targeted agents for Myeloid Malignancies.

Assess optimal patient selection and regimens for Stem Cell Transplantation in high-risk disease.

Course Details

• Price: $30.00
• Access Type: Lifetime
• Delivery Method: Google Drive Link, Offline
• Content Format: Video

What's Included

• Video lectures and recordings
• PDF study materials and resources

Key Features

• Expert-led instruction and content
• Comprehensive coverage of topic area
• Flexible learning schedule
• Lifetime access to all materials